Mesangioproliferative glomerulonephritis with IgM deposition: Clinical characteristics and outcome

Renal Failure

Volumn 22, Issue 4, 2000, Pages 445-457

  Little, Mark A ^a   Dorman, Anthony ^a   Gill, Denis ^b   Walshe, John J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b Temple St Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; FEMALE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOGLOBULIN DEPOSITION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYCLOSPORINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOGLOBULIN M; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDIES; STEROIDS;

EID: 0033923651     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100100886     Document Type: Article

References (24)

1. Cohen AH, Border WA, Glassock RJ: Nephrotic syndrome with Glomerular mesangial IgM deposits. Lab Invest 38:610-619, 1978.
2. O'Donoghue DJ, Lawler W, Hunt LP, Acheson EJ, Mallick NP: IgM-associated primary diffuse mesangial proliferative glomerulonephritis: Natural history and prognostic indicators. Q J Med 79:333-350, 1991.
3. Cavallo T, Johnson MP: Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits. Nephron 27:281-284, 1984.
4. del Moral RG Gomez-Morales M, Cortes V et al: Mononuclear cell subsets in IgM mesangial proliferative glomerulonephritis. Nephron 65:215-221, 1993.
5. Hishiki T, Tomino Y, Inokuchi S et al: Two adult cases of IgM-associated mesangial proliferative glomerulonephritis. Nippon Jinzo Gakkai Shi 36:942-946, 1994.
6. Bhasin HK, Abuelo G, Nayak RF, Esparza A: Mesangial proliferative glomerulonephritis. Lab Invest 39:21-29, 1978.
7. Hall C: Does IgM nephropathy exist? Presented at Society of DGH Nephrologists 21 Nov 1997.
8. Tejani A, Nicastri AD: Mesangial IgM nephropathy. Nephron 35:1-5, 1983.
9. Saha H, Mustonen J, Pasternack A, Helin H: Clinical follow-up of 54 patients with IgM nephropathy. Am J Nephrol 9:124-128, 1989.
10. Ji-Yun Y, Melvin T, Sibley R, Michael AF: No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Kidney Int 25:100-106, 1984.
11. International Study of Kidney disease in children: Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 20:765-71, 1981.
12. Al-Eisa A, Carter JE, Lirenman DS, Magil AB: Childhood IgM Nephropathy: Comparison with Minimal change disease: Nephron 72:37-43, 1996.
13. Southwest Pediatric Study Group: Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. Kidney Int 23:87-94, 1983.
14. Lin J-T, Lin C-Y, Huang F-U, Lee P-P, Chen C-H, Hsu H-C: A clinicopathological study of idiopathic nephrotic syndrome in children. Nippon Jinzo Gakkai Shi 37:442-450, 1995.
15. Hsu HC, Chen WY, Lin GJ, Chen L, Kao S-L, Huang C-C: Clinical and immunopathological study of mesangial IgM nephropathy: report of 41 cases. Histopathology 8:435-446, 1984.
16. Vilches AR, Turner DR, Cameron JS, Ogg CS, Chantler C, Williams DG: Significance of mesangial IgM deposition in "minimal change nephrotic syndrome" Lab Invest 46:10-15, 1982.
17. Pardo V, Riesgo I, Zilleruelo G, Strauss J: The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome. Am J Kidney Dis 3:264-269, 1984.
18. Gonzalo A, Mampaso F, Gallego N, Querada C, Fierro C, Ortuno J: Clinical significance of IgM mesangial deposits in the nephrotic syndrome. Nephron 41:246-249, 1985.
19. Looi EM, Wang F, Lam KL, Chua CT: Mesangial IgM in minimal change glomerular disease: A clinicopathological study in a Malaysian population. Pathology 17:41-44, 1985.
20. Hirszel P, Yamase HT, Carney WR et al: Mesangial proliferative glomeruloephritis with IgM deposits: clinicopathologic analysis and evidence for morphologic transition. Nephron 38:100-108, 1984.
21. Michael AF, Nevins TE, Raij E, Keane WF, Scheinman JI: Macromolecular transport in the glomerulus: studies of the mesangium and epithelium in vivo and in vitro. In: Immunologic mechanisms of renal disease. New york, Churchill Livingstone, 1979, pp167-213.
22. Kobayashi Y, Shigematsu H, Tgateno S, Hiki Y: Nephrotic syndrome with diffuse mesangial IgM deposits. Acta Pathol Jpn 32:307-317, 1982.
23. Sharma M, Sharma R, McCarthy ET, Savin VJ: "The FSGS factor": enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 10: 552-561, 1999.
24. Feld SM, Figueroa P, Savin V et al: Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 32: 230-237, 1998.